Enhancing precision medicine: Bispecific antibody-mediated targeted delivery of lipid nanoparticles for potential cancer therapy

Yue Zhang, Xiaoyan Gu, Lili Huang, Yani Yang and Jun He

International Journal of Pharmaceutics, 2024, 654, 123990
DOI: 10.1016/j.ijpharm.2024.123990

Combination non-targeted and sGRP78-targeted nanoparticle drug delivery outperforms either component to treat metastatic ovarian cancer

Jenna N. Sjoerdsma, Emily K. Bromley, Jaeho Shin, Tyvette Hilliard, Yueying Liu, Caitlin Horgan, Gyoyeon Hwang, Michael Bektas, David Omstead, Tanyel Kiziltepe, M. Sharon Stack and Basar Bilgicer

Journal of Controlled Release, 2024, 375, 438
DOI: 10.1016/j.jconrel.2024.09.014

Peptide-based strategies for overcoming multidrug-resistance in cancer therapy

Xiaofang Luo, Ye Wu, Xiaokun Zhang, Min Tang, Feiye Ju, Zuodong Qin, Gregory J Duns, Wei-Dong Zhang, Jiang-Jiang Qin and Xin Luan

Chinese Chemical Letters, 2025, 36, 109724
DOI: 10.1016/j.cclet.2024.109724

Mechanistic insights and therapeutic potential of glucose-regulated protein 78 in drug-resistant solid tumors: A comprehensive review

Priyamvada Bhamidipati, Ganji Purnachandra Nagaraju and Rama Rao Malla

International Journal of Biological Macromolecules, 2026, 340, 150001
DOI: 10.1016/j.ijbiomac.2025.150001

Diversity of extracellular HSP70 in cancer: advancing from a molecular biomarker to a novel therapeutic target

Binbin Hu, Guihong Liu, Kejia Zhao and Gao Zhang

Front. Oncol., 2024, 14
DOI: 10.3389/fonc.2024.1388999

Sanguinarine and Doxorubicin Inhibit Heat Shock Protein HSPA5 and Trigger ER Stress in Breast Cancer

Priyamvada Bhamidipati and Rama Rao Malla

Cell Biochem Biophys, 2025, 84, 1101
DOI: 10.1007/s12013-025-01927-8

GRP78 in Glioma Progression and Therapy: Implications for Targeted Approaches

Yue Yang, Wen Li, Yu Zhao, Minxuan Sun, Feifei Xing, Jiao Yang and Yuanshuai Zhou

Biomedicines, 2025, 13, 382
DOI: 10.3390/biomedicines13020382

GRP78 as a potential therapeutic target in cancer treatment: an updated review of its role in chemoradiotherapy resistance of cancer cells

Min Lin, Yan Mo, Cheng-min Li, Ying-zhe Liu and Xue-ping Feng

Med Oncol, 2025, 42
DOI: 10.1007/s12032-024-02586-0